National Health Investors, Inc. (NYSE:NHI)‘s stock had its “buy” rating reissued by investment analysts at Stifel Nicolaus in a note issued to investors on Wednesday, October 4th. They currently have a $82.00 price objective on the real estate investment trust’s stock. Stifel Nicolaus’ price objective would suggest a potential upside of 5.82% from the company’s previous close.
NHI has been the topic of a number of other research reports. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “sell” rating in a research note on Tuesday, July 18th. BidaskClub upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 17th. KeyCorp reiterated a “hold” rating on shares of National Health Investors in a research report on Sunday, September 17th. Finally, ValuEngine downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company’s stock. National Health Investors has a consensus rating of “Hold” and a consensus price target of $80.17.
National Health Investors (NYSE:NHI) opened at 77.49 on Wednesday. National Health Investors has a one year low of $66.31 and a one year high of $81.21. The stock’s 50 day moving average is $78.75 and its 200-day moving average is $76.90. The firm has a market capitalization of $3.18 billion, a PE ratio of 19.90 and a beta of 0.56.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm had revenue of $69.84 million for the quarter, compared to analysts’ expectations of $67.68 million. During the same period last year, the company posted $1.22 earnings per share. The business’s revenue for the quarter was up 14.1% compared to the same quarter last year. On average, analysts anticipate that National Health Investors will post $3.86 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This piece was originally published by BBNS and is the sole property of of BBNS. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://baseballnewssource.com/markets/national-health-investors-inc-nhi-given-buy-rating-at-stifel-nicolaus/1697478.html.
In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the sale, the insider now owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 5.19% of the company’s stock.
Several hedge funds have recently made changes to their positions in NHI. Carroll Financial Associates Inc. purchased a new position in shares of National Health Investors in the 2nd quarter valued at approximately $158,000. Quantbot Technologies LP acquired a new position in shares of National Health Investors in the first quarter worth $201,000. Yorktown Management & Research Co Inc acquired a new position in shares of National Health Investors in the second quarter worth $214,000. Allegis Investment Advisors LLC acquired a new position in shares of National Health Investors in the second quarter worth $216,000. Finally, Profund Advisors LLC raised its holdings in shares of National Health Investors by 4.3% in the second quarter. Profund Advisors LLC now owns 3,126 shares of the real estate investment trust’s stock worth $248,000 after acquiring an additional 130 shares during the last quarter. Institutional investors own 70.11% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with our FREE daily email newsletter.